Cargando…

Retraction Note: MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via downregulation of GADD45α

Detalles Bibliográficos
Autores principales: Yang, Peng, Ni, Fang, Deng, Rui-qing, Qiang, Guo, Zhao, Hua, Yang, Ming-zhen, Wang, Xin-yi, Xu, You-zhi, Chen, Li, Chen, Dan-lei, Chen, Zhi-jun, Kan, Li-xin, Wang, Si-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978439/
https://www.ncbi.nlm.nih.gov/pubmed/35379251
http://dx.doi.org/10.1186/s12943-022-01573-1
_version_ 1784680963484155904
author Yang, Peng
Ni, Fang
Deng, Rui-qing
Qiang, Guo
Zhao, Hua
Yang, Ming-zhen
Wang, Xin-yi
Xu, You-zhi
Chen, Li
Chen, Dan-lei
Chen, Zhi-jun
Kan, Li-xin
Wang, Si-Ying
author_facet Yang, Peng
Ni, Fang
Deng, Rui-qing
Qiang, Guo
Zhao, Hua
Yang, Ming-zhen
Wang, Xin-yi
Xu, You-zhi
Chen, Li
Chen, Dan-lei
Chen, Zhi-jun
Kan, Li-xin
Wang, Si-Ying
author_sort Yang, Peng
collection PubMed
description
format Online
Article
Text
id pubmed-8978439
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89784392022-04-05 Retraction Note: MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via downregulation of GADD45α Yang, Peng Ni, Fang Deng, Rui-qing Qiang, Guo Zhao, Hua Yang, Ming-zhen Wang, Xin-yi Xu, You-zhi Chen, Li Chen, Dan-lei Chen, Zhi-jun Kan, Li-xin Wang, Si-Ying Mol Cancer Retraction Note BioMed Central 2022-04-04 /pmc/articles/PMC8978439/ /pubmed/35379251 http://dx.doi.org/10.1186/s12943-022-01573-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Retraction Note
Yang, Peng
Ni, Fang
Deng, Rui-qing
Qiang, Guo
Zhao, Hua
Yang, Ming-zhen
Wang, Xin-yi
Xu, You-zhi
Chen, Li
Chen, Dan-lei
Chen, Zhi-jun
Kan, Li-xin
Wang, Si-Ying
Retraction Note: MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via downregulation of GADD45α
title Retraction Note: MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via downregulation of GADD45α
title_full Retraction Note: MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via downregulation of GADD45α
title_fullStr Retraction Note: MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via downregulation of GADD45α
title_full_unstemmed Retraction Note: MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via downregulation of GADD45α
title_short Retraction Note: MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via downregulation of GADD45α
title_sort retraction note: mir-362-5p promotes the malignancy of chronic myelocytic leukaemia via downregulation of gadd45α
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978439/
https://www.ncbi.nlm.nih.gov/pubmed/35379251
http://dx.doi.org/10.1186/s12943-022-01573-1
work_keys_str_mv AT yangpeng retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT nifang retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT dengruiqing retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT qiangguo retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT zhaohua retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT yangmingzhen retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT wangxinyi retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT xuyouzhi retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT chenli retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT chendanlei retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT chenzhijun retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT kanlixin retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a
AT wangsiying retractionnotemir3625ppromotesthemalignancyofchronicmyelocyticleukaemiaviadownregulationofgadd45a